Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Heureka Therapeutics ApS
APS
Active
Advertising protection
CVR 46220080
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2026 · <1 year old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Heureka Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MS
Maja Storm Engelstoft
Chief Executive Officer
Chief Executive Officer
2026
Former (2)
CC
Christoffer Clemmensen
Management
Management
2026 – 2026
JO
Jonas Odgaard Petersen
Management
Management
2026 – 2026
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nordic Alchemy Holding ApS
Company
25–33.32%
25–33.32%
2026
Science Studio Holding ApS
Company
25–33.32%
25–33.32%
2026
Ichiban Bio ApS
Company
20–24.99%
20–24.99%
2026
Engelstoft Holding ApS
Company
10–14.99%
10–14.99%
2026
mol.bio Holding ApS
Company
10–14.99%
10–14.99%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Heureka Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
